L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea
· Delayed Price · Currency is KRW 19,850
-250 (-1.24%)
Apr 1, 2025, 3:30 PM KST
L&C BIO Co.,LTD Revenue
L&C BIO Co.,LTD had revenue of 18.55B KRW in the quarter ending September 30, 2024, a decrease of -9.79%. This brings the company's revenue in the last twelve months to 70.03B, up 3.77% year-over-year. In the year 2023, L&C BIO Co.,LTD had annual revenue of 68.87B with 31.00% growth.
Revenue (ttm)
70.03B
Revenue Growth
+3.77%
P/S Ratio
6.25
Revenue / Employee
554.56M
Employees
130
Market Cap
450.30B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |